Media for Patients

COVID-19

January 08, 2021

COVID-19 Vaccine Q&A

On December 12, 2020, the National Psoriasis Foundation (NPF) COVID-19 Task Force released updated guidance regarding COVID-19 and psoriatic disease, including new guidance statements on vaccine use for people with psoriasis and/or psoriatic arthritis.

Since that time, NPF has heard many questions from members of our community. We compiled questions commonly asked of NPF leadership and staff with questions posed by community members on NPF social media channels and through the Patient Navigation Center to create this brief Q and A video with NPF COVID-19 Task Force co-chair, Dr. Joel Gelfand, M.D., of the University of Pennsylvania Perelman School of Medicine.

Visit the NPF COVID-19 Resource Center.

Here is the list of questions from our community that we cover in this video:

Questions about the guidance statements

Will taking the COVID-19 vaccine weaken my immune system?

When I receive the COVID-19 vaccine, should I continue to take my oral or biologic treatment? (Do biologics impact the efficacy of the vaccine?)

How should I prepare for receiving the vaccine?

Is there anything else I should know as a person living with psoriatic disease?

Questions posed by our community

Since I live with psoriasis, I know that I have an overactive immune system. Will my overactive immune system cancel out the impact of the vaccine?

Could taking the vaccine make my psoriasis worsen?

Could the side effects from the vaccine impact my psoriasis?

Do you know when people with underlying conditions might receive the vaccine?

Share

Related Items

Subscribe to our Podcast

We use cookies to offer you a better experience and analyze our site traffic. By continuing to use this website, you consent to the use of cookies in accordance with our Privacy Policy.